Sodium valproate: cacosmia and dysgeusia as uncommon side effects

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Vol3Nr4Y2023
Published Nov 15, 2023
DOI: https://doi.org/10.22551/2023.41.1004.10265
Clara Montalbano Accursio Raia Valerio Caruso Lavinia Migli

Abstract

Smell and taste disturbances are potential adverse reactions of many drugs used in Psychiatry, such as antidepressants, anti-Parkinson agents, lithium, minor and major tranquilizers. To our knowledge, only one clinical case regarding valproate and cacosmia has been reported so far. However, several anticonvulsants are reported to cause taste and smell disturbances, although the underlying etiology is currently unclear. Our patient developed cacosmia and dysgeusia when taking valproic acid, both effects quickly disappeared upon drug discontinuation. In this article we not only report this uncommon side effect, but we discuss the plausible mechanisms behind such an adverse reaction. Our case is to date the second similar case in the literature. The aim of the present article is to make clinicians informed about this very uncommon and unpleasant side effect.

##plugins.themes.bootstrap3.article.details##

Keywords

bipolar, valproate, smell, cacosmia, dysgeusia

References
1. Doty RL, Shah M, Bromley SM. Drug-induced taste disorders. Drug Saf. 2008;31(3):199-215. doi: 10.2165/00002018-200831030-00002. PMID: 18302445.
2. Naik BS, Shetty N, Maben EV. Drug-induced taste disorders. Eur J Intern Med. 2010;21(3):240-3. doi: 10.1016/j.ejim.2010.01.017. PMID: 20493431.
3. Tomita H, Yoshikawa T. Drug-related taste disturbances. Acta Otolaryngol Suppl. 2002;(546):116-21. doi: 10.1080/00016480260046490. PMID: 12132608.
4. Kishi T, Ikuta T, Matsuda Y, et al. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials. Mol Psychiatry. 2022;27(2):1136-1144. doi: 10.1038/s41380-021-01334-4. PMID: 34642461; PMCID: PMC9054678.
5. Nanau RM, Neuman MG. Adverse drug reactions induced by valproic acid. Clin Biochem. 2013;46(15):1323-38. doi: 10.1016/j.clinbiochem.2013.06.012. PMID: 23792104.
6. Alvarez P, Papaseit E, Pérez V, Bulbena A, Farré M. Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report. Actas Esp Psiquiatr. 2019;47(1):33-6. PMID: 30724329.
7. Baumann CR, Ott PM, Siegel AM. Hypogeusia as an adverse reaction of phenytoin. Br J Clin Pharmacol. 2004;58(6):678-9. doi: 10.1111/j.1365-2125.2004.02217.x. PMID: 15563368; PMCID: PMC1884645.
8. Avoni P, Contin M, Riva R, et al. Dysgeusia in epileptic patients treated with lamotrigine: report of three cases. Neurology. 2001;57(8):1521. doi: 10.1212/wnl.57.8.1521. PMID: 11673609.
9. Ghanizadeh A. Loss of taste and smell during treatment with topiramate. Eat Weight Disord. 2009;14(2-3):e137-8. doi: 10.1007/BF03327811. PMID: 19934627.
10. Rollin H. Drug-related gustatory disorders. Ann Otol Rhinol Laryngol. 1978;87(1 Pt 1):37-42. doi: 10.1177/000348947808700108. PMID: 623418.
11. Sachdeo R, Kramer LD, Rosenberg A, Sachdeo S. Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol. 1992;32(3):386-92. doi: 10.1002/ana.410320313. PMID: 1416808.
12. Thiermann F, Buchbauer G. Influence of drugs on smelling capacity. A review. Flavour Fragr J. 2017; 32:147–158. doi: 10.1002/ffj.3368
13. Abbott FS, Burton R, Orr J, et al. Valproic acid analysis in saliva and serum using selected ion monitoring (electron ionization) of the tert.-butyldimethylsilyl derivatives. J Chromatogr. 1982;227(2):433-44. doi: 10.1016/s0378-4347(00)80396-5. PMID: 6801067.
14. Bertolino M, Acerbi D, Canali S, et al. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester. Eur J Drug Metab Pharmacokinet. 1998;23(2):223-9. doi: 10.1007/BF03189344. PMID: 9725486.
15. Gao N, Lu M, Echeverri F, et al. Voltage-gated sodium channels in taste bud cells. BMC Neurosci. 2009;10:20. doi: 10.1186/1471-2202-10-20. PMID: 19284629; PMCID: PMC2660338.
16. Erikssen J, Seegaard E, Naess K. Letter: Side-effect of thiocarbamides. Lancet. 1975;1(7900):231-2. doi: 10.1016/s0140-6736(75)91417-8. PMID: 47475.
17. Henkin RI, Bradley DF. Hypogeusia corrected by Ni++ and Zn++. Life Sci II. 1970;9(12):701-9. doi: 10.1016/0024-3205(70)90278-x. PMID: 5478084.
18. Korkmazer N, Vurucu S, Demirkaya E, et al. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid. Brain Dev. 2006;28(8):515-20. doi: 10.1016/j.braindev.2006.03.003. PMID: 16682156.
19. Yilmaz Y, Tasdemir HA, Paksu MS. The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity. Eur J Paediatr Neurol. 2009;13(5):439-43. doi: 10.1016/j.ejpn.2008.08.007. PMID: 18922714.
20. Shinkai RS, Hatch JP, Schmidt CB, Sartori EA. Exposure to the oral side effects of medication in a community-based sample. Spec Care Dentist. 2006;26(3):116-20. doi: 10.1111/j.1754-4505.2006.tb01434.x. PMID: 16774189.
How to Cite
Montalbano, C., Raia, A., Caruso, V., & Migli, L. (2023). Sodium valproate: cacosmia and dysgeusia as uncommon side effects. Archive of Clinical Cases, 10(4), Arch Clin Cases. 2023;10(4):157-159. https://doi.org/10.22551/2023.41.1004.10265
Issue
Vol. 10 No. 4 (2023)
Section
Case Reports

Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.

Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.

Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.

How to Cite

Montalbano, C., Raia, A., Caruso, V., & Migli, L. (2023). Sodium valproate: cacosmia and dysgeusia as uncommon side effects. Archive of Clinical Cases, 10(4), Arch Clin Cases. 2023;10(4):157-159. https://doi.org/10.22551/2023.41.1004.10265